Recently, Prosthetic replacement of hip was recognized as a reliable technique for the treatment of avascular necrosis of femoral head in adult. There were many reports about post-operative evaluation of functional difference between hemiarthroplasty and total hip arthroplasty and which revealed that the revision rate for the total hip arthroplasty was less compared with the femoral endoprosthesis. Also, controversy was existed between the porous coating system and bone cement fixation. In order to evaluate the functional difference among each prosthetic replacement, authors reviewed the result of 10 cases of cementless unipolar endoprosthesis (abbreviated as UE), 10 cases of cementless bipolar endoprosthesis (abbreviated as BE), and 25 cases of cementless total hip replacement arthroplasy (abbreviated as THRA), performed at Department of Orthopaedic Surgery, Soon Chun Hyang University Hospital, during the period from September, 1985 to August, 1988. The following results were obtained: 1. The incidence was higher in 6th decade in UE, THRA groups, 4th decade in BE group. 2. The average follow up of UE, BE, and THRA groups were 30.7, 15.2, and 16.9 months, respectively. 3. By radiological classification of Marcus et al., the average stages of UE, BE, and THRA were 4.9, 4.0, and 5.3respectively. 4. According to Harris hip rating system, post-op. Harris scores were increased as much as 33.1, 37.2, and 43.4 in UE, BE, and THRA groups respectivelycompared with pre-op. score. 5. In this study, the last follow up results of hip function in BE, and THRA groups were better than that evaluated at 6 months after surgery in most cases. 6. External rotation, which was one of needed motion in cross leg sitting position, was significantly influenced by the degree of excision of joint capsule, the type of replacement prosthesis, the regimen of post-op. starting exercise, and a history of previous surgical treatment. 7. Because serious complications were not developed at recent follow up, the UE, BE, and THRA groups showed insignificant difference in functional difference in prosthetic replacement.
Adult ; Arthroplasty, Replacement ; Arthroplasty, Replacement, Hip ; Classification ; Follow-Up Studies ; Head ; Hemiarthroplasty ; Hip ; Humans ; Incidence ; Joint Capsule ; Leg ; Necrosis ; Prostheses and Implants

We experienced one case of anesthesia for liver transplantation in a 14 year old girl with Wilson's disease. The liver was donated from a patient with a brain tumor who was diagnosed as brain death. We monitored blood pressure, heart rate, cardiac output, pulmonary capillary wedge pressure, systemic vascular resistance, arterial pH, arterial PCO2, serum potassium, ionized calcium, glucose, and blood coagulation states including platelet count, prothrombin time, activated partial thromboplastin time and coagulation factor assay. We used isoflurane and nitrous oxide as the main inhalation anesthetics. The operation was performed without serious problem. The patient became conscious three hours after the operation.
Adolescent ; Anesthesia* ; Anesthetics, Inhalation ; Blood Coagulation ; Blood Coagulation Factors ; Blood Pressure ; Brain Death ; Brain Neoplasms ; Calcium ; Cardiac Output ; Female ; Glucose ; Heart Rate ; Hepatolenticular Degeneration ; Humans ; Hydrogen-Ion Concentration ; Isoflurane ; Liver Transplantation* ; Liver* ; Nitrous Oxide ; Partial Thromboplastin Time ; Platelet Count ; Potassium ; Prothrombin Time ; Pulmonary Wedge Pressure ; Vascular Resistance

Enterohemorrhagic Escherichia coli infection can cause hemorrhagic colitis and hemolytic uremic syndrome. Since 1994 we have carried out surveillance for this infection in the south of Choongnam Province, in Korea. We investigated the patients with diarrhea who had admitted in Soonchunhyang University Chunan Hospital(Total : 130, age; from infant to elderly), from May 1994 through February 1996. E. coli O157 : H7, O26 : H11, O128 : H2, O111 : H- serotype were assessed by the slide agglutination test. E. coli culture was positive in the 53(male 33, female 20) out of 130 patients with diarrhea. One case of E. coli O157 : H7 infection was identified. He was 30 days old infant lived in Dangjin rural area. He suffered from bloody diarrhea and anemia with acute renal failure, suggesting hemolytic uremic syndrome which is a well recognized complication of E. coli O157 : H7 infection. We have to aware of the possibility of outbreaks of E. coli O157 : H7 infection in this area.
Acute Kidney Injury ; Agglutination Tests ; Anemia ; Chungcheongnam-do ; Colitis ; Diarrhea ; Disease Outbreaks ; Enterohemorrhagic Escherichia coli ; Escherichia coli O157* ; Escherichia coli* ; Escherichia* ; Female ; Hemolytic-Uremic Syndrome ; Humans ; Infant ; Korea* ; Shiga Toxins

BACKGROUND: This study compared the bronchodilator efficacy and safety of tiotropium inhalation capsules (18microgram once daily) with a ipratropium metered dose inhaler (2 puffs of 20microgram q.i.d.) in patients with chronic obstructive pulmonary disease (COPD). METHOD: After the initial screening assessment and a two-week run-in period, patients received either tiotropium 18microgram once daily or ipratropium 40microgram four times daily over a period of 4 weeks in a double blind, double dummy, parallel group study. The outcome measures were the lung function, the daily records of the peak expiratory flow rate (PEFR), the patients' questionnaire, and the use of concomitant salbutamol. The forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC) were measured 5 minutes before inhalation, and 0.5, 1, 2 and 3 hours after inhaling the study drug on days 0, 14 and 28. RESULT: In 16 centers, 134 patients with a mean (SD) age of 66 (7) years and a predicted FEV1 of 42 (12)% were analyzed. The trough FEV1 response was significantly higher in the tiotropium group than in the ipratropium group after a four-week treatment period. The weekly mean morning PEFR of the tiotropium group was consistently higher than that of the ipratropium group during the 4-week treatment period with differences ranging from 12.52 to 13.88 l/min, which were statistically significant. Tiotropium was well tolerated by the COPD patients during the 4-week treatment period and had a similar safety profile to ipratropium. CONCLUSION: This study shows that tiotropium administrated once daily has a superior bronchodilator effect with a similar safety profile in treating COPD patients compared with ipratropium, inhaled four times daily.
Adult* ; Albuterol ; Bronchodilator Agents ; Capsules ; Forced Expiratory Volume ; Humans ; Inhalation ; Ipratropium* ; Lung ; Mass Screening ; Metered Dose Inhalers ; Outcome Assessment (Health Care) ; Peak Expiratory Flow Rate ; Pulmonary Disease, Chronic Obstructive* ; Surveys and Questionnaires ; Vital Capacity ; Tiotropium Bromide